Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial
2024-04-22 20:30
GT20029 China Phase II Trial For AGA Reached Primary Endpoint
2024-04-22 09:53
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards
2024-04-22 09:00
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards
2024-04-22 09:00
BGI Genomics Leads Innovation with Inaugural Clinical Lab in Uruguay
2024-04-22 08:27
CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US
2024-04-20 01:11
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success
2024-04-19 21:00
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
2024-04-19 19:00
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
2024-04-19 19:00
Cognivia Secures Strategic 15.5M€ Funding to Empower Drug Development with AI-ML Solutions
2024-04-18 21:00
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
2024-04-18 20:00
Siriraj Hospital Shines Spotlight on TAVI Procedure as Alternative for High-Risk Patients Requiring Aortic Valve Replacement
2024-04-18 15:01
TaiGen Successfully Completes TG-1000 Phase III Study
2024-04-18 11:03
Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL"
2024-04-18 11:00
Henlius Releases 2023 ESG Report: Pursuing Sustainable Development with Patient-centricity
2024-04-17 20:32
Q1 2024 Revenue and Business Update
2024-04-17 15:05
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN ASIA
2024-04-17 11:22
Kind Pharmaceuticals Announces Settlement
2024-04-17 00:17
Mabwell Releases Preclinical Study Results of Multiple Innovative Drugs Released at the 2024 AACR Annual Meeting
2024-04-16 22:00
CSafe Elevates Cell and Gene Therapy Transport with Reusable Cryogenic Solution
2024-04-16 20:47
1
2
3
4
5
374